Top Menu

Annual Meeting

LIGHT 2023: Amsterdam

October 5

VenueTBA. Stay tuned for further information !

Past Program

LIGHT 5 2019: Paris 

September 4

Hotel Plaza Athenee’ Paris

9am – 4:30pm

Continental Breakfast 8:00 – 8:50 am

8:50 am Welcome

Central Serous

9:00 The effects of treatment on acute and chronic central serous chorioretinopathy by subthreshold micropulse laser. Maciej Gawecki and Andrzej Grzybowski, Poland

9:20 Focal and diffuse chronic central serous chorioretinopathy treated with half-dose photodynamic therapy or subthreshold micropulse laser without performing a high-density grid. Jan EE Keunen, The Netherlands

Diabetic Macular Edema

9:45 Minimally invasive laser treatment combined with intravitreal injection of anti-vascular endothelial growth factor for diabetic macular oedema. Kishiko Ohkoshi and Keiji Inagaki, Japan

10:05 OCTA guided threshold laser photocoagulation using micropulse laser for persistent diabetic macular edema with leaking microaneurysm. Tatsunori Komoto and Kishiko Ohkoshi, Japan

Break 10:25-10:45

10:45 Teleophthalmology image-based navigated retinal laser therapy for diabetic macular edema: A concept of retinal telephotocoagulation.Igor Kozak, United Arab Emirates

11:05 Yellow Navigated Subthreshold Diode Microsecond Pulsing (YNSDMP) in Diabetic macular edema. Carlos Orduna, Spain

Age-Related Macular Degeneration

11:25 Mesopic visual function in AMD: characteristics, laser treatment responses and prognostic implications. Stephen H Sinclair and Jeffrey K Luttrull, USA

LUNCH 11:45 am – 1:30 pm

1:30 Nanosecond laser treatment in early and intermediate AMD: 24-month results on macular function. Eugenio Sancin, Italy

1:50 Panmacular subthreshold diode micropulse laser (SDM) slows progression of age-related geographic atrophy. Jeffrey K Luttrull, Stephen H Sinclair, Solly Elmann, David B Chang, USA

2:10 Real World Data: Routine subthreshold diode micropulse laser (SDM) improves all AMD outcome measures. Jeffrey K Luttrull, Nicholas Boucher,a USA

Novel Applications

2:30 Subthreshold laser photocoagulation for Pachychoroid neovasculopathy. Kunihiko Hirosawa and Kishiko Ohkoshi, Japan

 2:50 Subthreshold laser treatment for retinal arterial macroaneurysm. Maurizio Battaglia Parodi, A Arrigo, F Rajabian, Francesco Bandello, Italy

3:10 577 or 810nm? What is the difference? Kinetics of primary laser mechanism revealed and correlation with in-vivo studies. David B Chang and Jeffrey K Luttrull, USA

Break 3:30

LIGHT Best Practices Policy Formulation

4:00 Problems and controversies. Urgent Retinal Laser Issues: Wavelength; Titration vs. Fixed Parameters; Technique; Proposal for LIGHT Standards Recommendations. Jan Keunen, The Netherlands